HAT therapy for sepsis: A review of the therapeutic rationale and current clinical evaluation status.

J Intensive Med

Department of General ICU, The First Affiliated Hospital of Zhengzhou University, Henan Key Laboratory of Critical Care Medicine, Zhengzhou Key Laboratory of Sepsis, Zhengzhou 450052, Henan, China.

Published: October 2023

AI Article Synopsis

  • Vitamin C-based cluster therapy (HAT), which includes hydrocortisone, vitamin C, and thiamine, is a new potential treatment for sepsis alongside conventional methods.
  • While there is a strong theoretical basis for this therapy, its effectiveness in clinical settings is still unclear.
  • The review evaluates existing studies on HAT therapy’s efficacy and aims to guide future clinical applications for treating sepsis.

Article Abstract

Vitamin C-based cluster therapy, which involves the combined application of hydrocortisone, vitamin C, and thiamine (HAT), is a recently proposed new treatment option for sepsis on top of conventional treatment. This therapy has a strong theoretical basis, but its clinical efficacy remains inconclusive. This review summarizes the rationale for HAT therapy for sepsis and describes the evaluation of its efficacy in clinical observational studies and randomized controlled trials, with the aim of providing a reference for the future clinical practice application of HAT therapy in sepsis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658041PMC
http://dx.doi.org/10.1016/j.jointm.2023.04.003DOI Listing

Publication Analysis

Top Keywords

hat therapy
12
therapy sepsis
12
hat
4
sepsis
4
sepsis review
4
review therapeutic
4
therapeutic rationale
4
rationale current
4
clinical
4
current clinical
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!